Impact of virgin olive oil and phenol-enriched virgin olive oils on the HDL proteome in hypercholesterolemic subjects: A double blind, randomized, controlled, cross-over clinical trial (VOHF study)

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Pedret, Anna ^a   Catalán, Úrsula ^a   Fernández Castillejo, Sara ^a   Farràs, Marta ^b,c   Valls, Rosa M ^a   Rubió, Laura ^a,d   Canela, Núria ^e   Aragonés, Gerard ^e   Romeu, Marta ^f   Castañer, Olga ^b   De La Torre, Rafael ^b,g   Covas, Maria Isabel ^b   Fitó, Montse ^b   Motilva, Maria José ^d   Solà, Rosa ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF LLEIDA   (Spain)

^e UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^f FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^g UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN D; BETA ALANYLHISTIDINE DIPEPTIDASE; BETA1 INTEGRIN; BPI FOLD CONTAINING FAMILY B MEMBER 1 PROTEIN; CARBONATE DEHYDRATASE; CARBONIC ANHYDRASE 6; CD209 ANTIGEN; CD5 ANTIGEN LIKE PROTEIN; GLUCONOLACTONASE; HERMES ANTIGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; IG HEAVY CHAIN V I REGION HG3; IG LAMBDA 1 CHAIN C REGION; IG LAMBDA 2 CHAIN C REGION; IG LAMBDA 7 CHAIN C REGION; IMMUNOGLOBULIN LAMBDA CHAIN; LACTONASE 3; MULTIMERIN 2 PROTEIN; PHENOL ENRICHED VIRGIN OLIVE OIL; PROTEOME; RETINOL BINDING PROTEIN 4; SONIC HEDGEHOG PROTEIN; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG; VIRGIN OLIVE OIL; OLIVE OIL; PHENOL DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CELL ADHESION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEART PROTECTION; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; INNATE IMMUNITY; LIPID COMPOSITION; LIPID TRANSPORT; MALE; OXIDATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UPREGULATION; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

THYMUS VULGARIS;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OLIVE OIL; PHENOLS; PROTEOME; TREATMENT OUTCOME;

EID: 84936818622     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129160     Document Type: Article

References (41)

1. Covas M-I, Nyyssönen K, Poulsen HE, Kaikkonen J, Zunft H-JF, Kiesewetter H, et al. (2006) The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 145: 333-341. Available: PMID: 16954359
2. Marrugat J, Covas M-I, Fitó M, Schröder H, Miró-Casas E, Gimeno E, et al. (2004) Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation - a randomized controlled trial. Eur J Nutr 43: 140-147. Available: PMID: 15168036
3. Rubió L, Valls R-M, Macià A, Pedret A, Giralt M, Romero M-P, et al. (2012) Impact of olive oil phenolic concentration on human plasmatic phenolic metabolites. Food Chem 135: 2922-2929. doi: 10.1016/j.foodchem.2012.07.085 PMID: 22980891
4. Suárez M, Valls RM, Romero M-P, Macià A, Fernández S, Giralt M, et al. (2011) Bioavailability of phenols from a phenol-enriched olive oil. Br J Nutr 106: 1691-1701. doi: 10.1017/S0007114511002200 PMID: 21736768
5. Servili M, Selvaggini R, Esposto S, Taticchi A, Montedoro G, Morozzi G (2004) Health and sensory properties of virgin olive oil hydrophilic phenols: agronomic and technological aspects of production that affect their occurrence in the oil. J Chromatogr A 1054: 113-127. PMID: 15553137
6. Herrmann F, Wink M (2011) Synergistic interactions of saponins and monoterpenes in HeLa cells, Cos7 cells and in erythrocytes. Phytomedicine 18: 1191-1196. doi: 10.1016/j.phymed.2011.08.070 PMID: 21968386
7. Rubió L, Motilva M-J, Macià A, Ramo T, Romero M-P (2012) Development of a phenol-enriched olive oil with both its own phenolic compounds and complementary phenols from thyme. J Agric Food Chem 60: 3105-3112. doi: 10.1021/jf204902w PMID: 22380740
8. Boros B, Jakabová S, Dörnyei A, Horváth G, Pluhár Z, Kilár F, et al. (2010) Determination of polyphenolic compounds by liquid chromatography-mass spectrometry in Thymus species. J Chromatogr A 1217: 7972-7980. doi: 10.1016/j.chroma.2010.07.042 PMID: 20692666
9. Shah AS, Tan L, Long JL, Davidson WS (2013) Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J Lipid Res 54: 2575-2585. doi: 10.1194/jlr.R035725 PMID: 23434634
10. Burillo E, Mateo-Gallego R, Cenarro A, Fiddyment S, Bea AM, Jorge I, et al. (2012) Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome. Lipids Health Dis 11: 116. doi: 10.1186/1476-511X-11-116 PMID: 22978374
11. Rubió L, Farràs M, de La Torre R, Macià A, Romero M-P, Valls R-M, et al. (2014) Metabolite profiling of olive oil and thyme phenols after a sustained intake of two phenol-enriched olive oils by humans: Identification of compliance markers. Food Res Int 65: 59-68.
12. Morelló J-R, Motilva M-J, Tovar M-J, Romero M-P (2004) Changes in commercial virgin olive oil (cv Arbequina) during storage, with special emphasis on the phenolic fraction. Food Chem 85: 357-364.
13. Criado M-N, Romero M-P, Casanovas M, Motilva M-J (2008) Pigment profile and colour of monovarietal virgin olive oils from Arbequina cultivar obtained during two consecutive crop seasons. Food Chem 110: 873-880.
14. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353. PMID: 13252080
15. Lepedda AJ, Nieddu G, Zinellu E, De Muro P, Piredda F, Guarino A, et al. (2013) Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker. Oxid Med Cell Longev 2013: 385214. doi: 10.1155/2013/385214 PMID: 24454983
16. Tan Y, Liu TR, Hu SW, Tian D, Li C, Zhong JK, et al. (2014) Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions. PLoS One 9: e94264. doi: 10.1371/journal.pone.0094264 PMID: 24736723
17. Alwaili K, Bailey D, Awan Z, Bailey SD, Ruel I, Hafiane A, et al. (2012) The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta 1821: 405-415. doi: 10.1016/j.bbalip.2011.07.013 PMID: 21840418
18. Castañer O, Corella D, Covas M-I, Sorlí J V, Subirana I, Flores-Mateo G, et al. (2013) In vivo transcriptomic profile after a Mediterranean diet in high-cardiovascular risk patients: a randomized controlled trial. Am J Clin Nutr 98: 845-853. doi: 10.3945/ajcn.113.060582 PMID: 23902780
19. Konstantinidou V, Covas M-I, Sola R, Fitó M (2013) Up-to date knowledge on the in vivo transcriptomic effect of the Mediterranean diet in humans. Mol Nutr Food Res 57: 772-783. doi: 10.1002/mnfr.201200613 PMID: 23417868
20. Farràs M, Valls RM, Fernández-Castillejo S, Giralt M, Solà R, Subirana I, et al. (2013) Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial. J Nutr Biochem 24: 1334-1339. doi: 10.1016/j.jnutbio.2012.10.008 PMID: 23333095
21. Rodríguez-Gutiérrez G, Duthie GG, Wood S, Morrice P, Nicol F, Reid F, et al. (2012) Alperujo extract, hydroxytyrosol, and 3,4-dihydroxyphenylglycol are bioavailable and have antioxidant properties in vitamin E-deficient rats-a proteomics and network analysis approach. Mol Nutr Food Res 56: 1137-1147. doi: 10.1002/mnfr.201100808 PMID: 22648667
22. Hernáez Á, Fernández-Castillejo S, Farràs M, Catalán Ú, Subirana I, Montes R, et al. (2014) Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial. Arterioscler Thromb Vasc Biol 34: 2115-2119. doi: 10.1161/ATVBAHA.114.303374 PMID: 25060792
23. Giordano E, Davalos A, Nicod N, Visioli F (2014) Hydroxytyrosol attenuates tunicamycin-induced endoplasmic reticulum stress in human hepatocarcinoma cells. Mol Nutr Food Res 58: 954-962. doi: 10.1002/mnfr.201300465 PMID: 24347345
24. Annema W, von Eckardstein A (2013) High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J 77: 2432-2448. PMID: 24067275
25. Mai¨ga SF, Kalopissis A-D, Chabert M (2014) Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes. Biochimie 96: 56-66. doi: 10.1016/j.biochi.2013.08.027 PMID: 24012775
26. Solá R, Fitó M, Estruch R, Salas-Salvadó J, Corella D, de La Torre R, et al. (2011) Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial. Atherosclerosis 218: 174-180. doi: 10.1016/j.atherosclerosis.2011.04.026 PMID: 21640348
27. Martínez-López S, Sarriá B, Sierra-Cinos JL, Goya L, Mateos R, Bravo L (2014) Realistic intake of a flavanol-rich soluble cocoa product increases HDL-cholesterol without inducing anthropometric changes in healthy and moderately hypercholesterolemic subjects. Food Funct 5: 364-374. doi: 10.1039/c3fo60352k PMID: 24394704
28. Rached F, Santos RD, Camont L, Miname MH, Lhomme M, Dauteuille C, et al. (2014) Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome. J Lipid Res 55: 2509-2520. doi: 10.1194/jlr.M051631 PMID: 25341944
29. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, et al. (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21: 542-547. PMID: 11304470
30. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113: 1760-1767. PMID: 16567568
31. Faraj M, Messier L, Bastard JP, Tardif A, Godbout A, Prud'homme D, et al. (2006) Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia 49: 1637-1646. PMID: 16752182
32. Santos-González M, López-Miranda J, Pérez-Jiménez F, Navas P, Villalba JM (2012) Dietary oil modifies the plasma proteome during aging in the rat. Age (Dordr) 34: 341-358. doi: 10.1007/s11357-011-9239-z PMID: 21472381
33. Wei Y-J, Huang Y-X, Zhang X-L, Li J, Huang J, Zhang H, et al. (2008) Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study. Biomarkers 13: 535-548. PMID: 18979643
34. Ingelsson E, Sundström J, Melhus H, Michae¨lsson K, Berne C, Vasan R, et al. (2009) Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 206: 239-244. doi: 10.1016/j.atherosclerosis.2009.02.029 PMID: 19339013
35. Van Dijk A, Vermond RA, Krijnen PAJ, Juffermans LJM, Hahn NE, Makker SP, et al. (2010) Intravenous clusterin administration reduces myocardial infarct size in rats. Eur J Clin Invest 40: 893-902. doi: 10.1111/j.1365-2362.2010.02345.x PMID: 20854280
36. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F (2008) Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 6: 892-906. doi: 10.1158/1541-7786.MCR-07-2195 PMID: 18567794
37. Lam CK, Zhang Z, Yu H, Tsang S-Y, Huang Y, Huang Y, et al. (2008) Apple polyphenols inhibit plasma CETP activity and reduce the ratio of non-HDL to HDL cholesterol. Mol Nutr Food Res 52: 950-958. doi: 10.1002/mnfr.200700319 PMID: 18496813
38. Kronenberg F, Stühlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, von Eckardstein A, et al. (2000) Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 36: 751-757. PMID: 10987595
39. Chang P-Y, Lee C-M, Hsu H-C, Lin H-J, Chien K-L, Chen M-F, et al. (2012) Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan. Lipids Health Dis 11: 162. doi: 10.1186/1476-511X-11-162 PMID: 23173569
40. Birner-Gruenberger R, Schittmayer M, Holzer M, Marsche G (2014) Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology. Prog Lipid Res 56C: 36-46.
41. Mangé A, Goux A, Badiou S, Patrier L, Canaud B, Maudelonde T, et al. (2012) HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach. PLoS One 7: e34107. doi: 10.1371/journal.pone.0034107 PMID: 22470525